Following the acquisition, Trident will become the wholly owned subsidiary of INC Research and will be operating as Trident Clinical Research, an INC Research company, through its offices in Sydney, Brisbane, Melbourne, Adelaide, Auckland and Mumbai.
Trident Clinical Research managing director and co-founder Garth Tierney said they look forward to leveraging INC Research’s resources and Trusted Process methodology to enhance their services.